Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cellebrite DI (CLBT) Shares Outstanding (Diluted Average): 2020-2024

Historic Shares Outstanding (Diluted Average) for Cellebrite DI (CLBT) over the last 3 years, with Dec 2024 value amounting to $209.5 million.

  • Cellebrite DI's Shares Outstanding (Diluted Average) rose 10.16% to $209.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $209.5 million, marking a year-over-year increase of 10.16%. This contributed to the annual value of $209.5 million for FY2024, which is 10.16% up from last year.
  • Latest data reveals that Cellebrite DI reported Shares Outstanding (Diluted Average) of $209.5 million as of Q4 2024, which was up 10.16% from $190.2 million recorded in Q4 2023.
  • Over the past 5 years, Cellebrite DI's Shares Outstanding (Diluted Average) peaked at $209.5 million during Q4 2024, and registered a low of $125.4 million during Q2 2021.
  • In the last 3 years, Cellebrite DI's Shares Outstanding (Diluted Average) had a median value of $195.4 million in 2022 and averaged $196.7 million.
  • As far as peak fluctuations go, Cellebrite DI's Shares Outstanding (Diluted Average) skyrocketed by 54.98% in 2022, and later fell by 3.66% in 2023.
  • Over the past 5 years, Cellebrite DI's Shares Outstanding (Diluted Average) (Quarterly) stood at $158.0 million in 2020, then grew by 3.41% to $199.1 million in 2021, then dropped by 1.85% to $195.4 million in 2022, then declined by 2.68% to $190.2 million in 2023, then increased by 10.16% to $209.5 million in 2024.
  • Its Shares Outstanding (Diluted Average) was $209.5 million in Q4 2024, compared to $190.2 million in Q4 2023 and $204.4 million in Q3 2023.